RedHill Biopharma (RDHL) Assets (2011 - 2026)
RedHill Biopharma's Assets was $26.27 million in the quarter ended Jun 30, 2026, up 43.0% from $18.38 million a year earlier.
Powered by 
Analysis
RedHill Biopharma (RDHL) Assets (2011 - 2026) Analysis & Trends
As of Dec 31, 2025, Assets at RedHill Biopharma came in at $25.35 million, up 40.5% from the prior year.
- Assets shows a five-year compound annual growth rate of -32.5% (years ended Dec 2020 to Dec 2025).
- In earlier years, Assets was $18.04 million in the year ended Dec 31, 2024 (-21.7%), $23.05 million in the year ended Dec 31, 2023 (-85.5%), $158.87 million in the year ended Dec 31, 2022 (-12.3%) and $181.19 million in the year ended Dec 31, 2021 (+0.5%).
- The figure for the quarter ended Jun 30, 2026 marks the highest quarterly Assets since the quarter ended Jun 30, 2023.
- Compared with a year earlier, Assets was higher in two of the last four quarters, with growth averaging 11.3%.
- The best year-over-year quarter for Assets over five years was the quarter ended Jun 30, 2026 (growth of 43.0%); the worst was the quarter ended Dec 31, 2023 (a decline of 85.5%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.90 Bn | 1,105.48 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 617.06 Bn | 535.59 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 501.38 Bn | 474.49 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 297.92 Bn | 261.91 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 261.31 Bn | 235.00 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 236.29 Bn | 191.69 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 190.40 Bn | 164.60 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 169.55 Bn | 116.19 Bn | 10.94 Bn | 201.13 Bn |
| 10 | RedHill Biopharma | 1.48 Mn | -15.13 Mn | - | 26.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.27 Mn |
| Dec 31, 2025 | 25.35 Mn |
| Jun 30, 2025 | 18.38 Mn |
| Dec 31, 2024 | 18.04 Mn |
| Jun 30, 2024 | 22.02 Mn |
| Dec 31, 2023 | 23.05 Mn |
| Jun 30, 2023 | 35.04 Mn |
| Mar 31, 2023 | 58.83 Mn |
| Dec 31, 2022 | 158.87 Mn |
| Sep 30, 2022 | 157.19 Mn |
| Jun 30, 2022 | 167.97 Mn |
| Mar 31, 2022 | 167.05 Mn |
| Dec 31, 2021 | 181.19 Mn |
| Sep 30, 2021 | 186.34 Mn |
| Jun 30, 2021 | 203.67 Mn |
| Mar 31, 2021 | 220.12 Mn |
| Dec 31, 2020 | 180.24 Mn |
| Sep 30, 2020 | 168.98 Mn |
| Jun 30, 2020 | 166.37 Mn |
| Mar 31, 2020 | 143.48 Mn |
API Access
RedHill Biopharma Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=RDHL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "RDHL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=RDHL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();